Responses
Oral Presentations
Abstract session: Osteoporosis
OP0247 Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate– a Randomized Placebo-Controlled Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.